Advertisement
Entire Site
Articles/Fact Sheets
Ask the Experts
Library of Older Articles
Recent Conference Coverage
Previous Conference Coverage
Upcoming Conferences
Conference Reports From Other Sources
0
Email
Glossary
The Body Covers: The 39th Annual Meeting of the Infectious Diseases Society of America
Conference Summaries
Pablo Tebas on IDSA
HIV/AIDS: Antiretroviral Therapy (Poster Session 87)
HAART and the Management of HIV-1 Infection: Can Short-Term Changes in the Plasma HIV-1 RNA Level Predict Long-Term Response to Therapy? (Poster 652)
Coverage by
Pablo Tebas, M.D.
Predicting the Unpredictable: The Transmission of Drug-Resistant HIV (Poster 655)
Coverage by
Pablo Tebas, M.D.
Efficacy of Lopinavir (LPV) in Heavily Pretreated Patients (Poster 675)
Coverage by
Pablo Tebas, M.D.
Initiation of Highly Active Antiretroviral Therapy (HAART) at CD4 Level 350: Assessment of Disease Progression, and Drug Failure, Toxicity, and Resistance (Poster 687)
Coverage by
Pablo Tebas, M.D.
Simplification of Protease Inhibitor (PI)-Containing HAART Regimen with Abacavir (ABC) Maintains Viral Suppression and Favorable Adherence in HIV-1 Infected Adults (COL30305) (Poster 689)
Coverage by
Douglas T. Dieterich, M.D.
Retrospective Review of Nevirapine-Induced Hepatotoxicity in HIV/HCV Co-Infected Patients in a Community Health Center (Poster 691)
Coverage by
Douglas T. Dieterich, M.D.
A Retrospective Cohort Study of the Durability of Antiretroviral Therapy Using Nevirapine versus Antiretroviral Therapy Using Protease Inhibitors (Poster 693)
Coverage by
Douglas T. Dieterich, M.D.
Clinical Experience of Amprenavir (APV) Following Nelfinavir (NFV) Use (Poster 694)
Coverage by
Douglas T. Dieterich, M.D.
Final Results of a Pilot, 48-Week Study of Amprenavir/Abacavir/Lamivudine (APV/ABC/3TC) in ART-Naive Subjects with HIV-1 Infection (COL30309) (Poster 696)
Coverage by
Douglas T. Dieterich, M.D.
The Compact Quad, Combivir/Abacavir/Efavirenz (COM/ABC/EFV) -- Preliminary 48-Week Results (COL30336) (Poster 697)
Coverage by
Douglas T. Dieterich, M.D.
Effect of Hepatitis G Co-Infection on Response to Antiretroviral Treatment In HIV-Infected Patients (Poster 698)
Coverage by
Pablo Tebas, M.D.
Once-Weekly Epoetin Alfa Increases Hemoglobin and Improves Quality of Life in Anemic HIV-Positive Patients (Poster 708)
Coverage by
Douglas T. Dieterich, M.D.
Relationship Between Prior Antiretroviral Therapy (ART) and Genotypic Testing (GT) Among a Large Cohort of HIV-1 Isolates (Poster 713)
Coverage by
Douglas T. Dieterich, M.D.
Ability of Patients with HIV Infection to Predict Changes in Their Own CD4+ Lymphocyte and Viral Load Measurements (Poster 716)
Coverage by
Pablo Tebas, M.D.
HIV/AIDS: Epidemiology/Prevention (Poster Session 88)
Disclosure of HIV Status to Sexual Partners and Association with Condom Use (Poster 748)
Coverage by
Pablo Tebas, M.D.
Cutting-Edge Issues in HIV Medicine (Symposium)
Challenges of Antiretroviral Therapy in the Developing World
Coverage by
Pablo Tebas, M.D.
Future Horizons in Antiretroviral Drugs
Coverage by
Pablo Tebas, M.D.
Structured Treatment Interruption: Panacea or Pandora?
Coverage by
Pablo Tebas, M.D.
HIV and HCV Co-Infection -- Current Status and Future Directions
Coverage by
Pablo Tebas, M.D.
Return to The Body's coverage of
The
39th Annual Meeting of the Infectious Diseases Society of America
.
0
Email
Glossary
Advertisement